Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year

NCT02889809 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

477

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone furoate
DRUG: Placebo
DRUG: Montelukast
DRUG: Short Acting Beta 2 Agonist

Sponsor

GlaxoSmithKline